ElectroCore outlines 30% to 40% 2027 revenue growth and targets positive adjusted EBITDA by end of 2027
FROM THE WIRE · SEEKINGALPHA.COM
electroCore Q3 2026: record sales, narrowed losses, revised revenue outlook, and FDA Quell CIPN filing.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishRevenue growth guidance and a profitability target may affect valuation of the ECOR stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01electroCore reported record sales in the third quarter of 2026.
- 02The company narrowed its losses and revised its revenue outlook.
- 03It filed with the FDA for Quell in CIPN.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets